- Home
- COLL vs HY Comparison
COLL vs HY Comparison
Compare COLL & HY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- HY
- Stock Information
- Founded
- COLL 2002
- HY 1991
- Country
- COLL United States
- HY United States
- Employees
- COLL N/A
- HY N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- HY Construction/Ag Equipment/Trucks
- Sector
- COLL Health Care
- HY Industrials
- Exchange
- COLL Nasdaq
- HY Nasdaq
- Market Cap
- COLL 910.2M
- HY 735.1M
- IPO Year
- COLL 2015
- HY N/A
- Fundamental
- Price
- COLL $30.00
- HY $41.99
- Analyst Decision
- COLL Strong Buy
- HY Strong Buy
- Analyst Count
- COLL 5
- HY 2
- Target Price
- COLL $43.60
- HY $80.00
- AVG Volume (30 Days)
- COLL 444.8K
- HY 70.6K
- Earning Date
- COLL 05-08-2025
- HY 05-06-2025
- Dividend Yield
- COLL N/A
- HY 3.34%
- EPS Growth
- COLL 43.56
- HY 11.05
- EPS
- COLL 1.86
- HY 8.04
- Revenue
- COLL $631,449,000.00
- HY $4,308,200,000.00
- Revenue This Year
- COLL $20.00
- HY N/A
- Revenue Next Year
- COLL $3.93
- HY $3.75
- P/E Ratio
- COLL $16.09
- HY $5.22
- Revenue Growth
- COLL 11.41
- HY 4.61
- 52 Week Low
- COLL $27.28
- HY $40.49
- 52 Week High
- COLL $42.29
- HY $84.44
- Technical
- Relative Strength Index (RSI)
- COLL 51.96
- HY 33.17
- Support Level
- COLL $29.01
- HY $40.49
- Resistance Level
- COLL $30.53
- HY $42.35
- Average True Range (ATR)
- COLL 0.89
- HY 1.30
- MACD
- COLL 0.04
- HY -0.12
- Stochastic Oscillator
- COLL 62.91
- HY 23.51
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.